JPMorgan analyst Casey Woodring raised the firm’s price target on Qiagen (QGEN) to $60 from $55 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q4 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Qiagen Tops 2025 Guidance and Sets Ambitious 2026 Growth Targets
- Qiagen price target lowered to $55 from $55.40 at Citi
- Qiagen price target raised to $58 from $55 at Barclays
- Qiagen: Solid Long‑Term Fundamentals but Near‑Term Headwinds Justify Hold Rating
- Qiagen price target raised to $59 from $57 at Jefferies